4.7 Article

Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia A Randomized Trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Critical Care Medicine

Management of Community-acquired Pneumonia in Adults

Grant W. Waterer et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Critical Care Medicine

Microvascular thrombosis and multiple organ dysfunction syndrome

Satoshi Gando

CRITICAL CARE MEDICINE (2010)

Review Critical Care Medicine

Inflammation and coagulation

Marcel Levi et al.

CRITICAL CARE MEDICINE (2010)

Review Critical Care Medicine

Adjunctive Therapy in Community-Acquired Pneumonia

Richard G. Wunderink

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Article Critical Care Medicine

4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia

Sachin Yende et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Pharmacology & Pharmacy

Multiplicity and flexibility in clinical trials

Werner Brannath et al.

PHARMACEUTICAL STATISTICS (2007)

Article Physiology

Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure

KE Welty-Wolf et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)

Article Critical Care Medicine

Does disseminated intravascular coagulation lead to multiple organ failure?

JL Vincent et al.

CRITICAL CARE CLINICS (2005)

Article Critical Care Medicine

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

PF Laterre et al.

CRITICAL CARE MEDICINE (2005)

Article Mathematical & Computational Biology

A general statistical principle for changing a design any time during the course of a trial

HH Müller et al.

STATISTICS IN MEDICINE (2004)

Review Cardiac & Cardiovascular Systems

Bidirectional relation between inflammation and coagulation

M Levi et al.

CIRCULATION (2004)

Article Medicine, General & Internal

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial

E Abraham et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Article Critical Care Medicine

Blockade of tissue factor - Treatment for organ injury in established sepsis

MS Carraway et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)

Article Critical Care Medicine

Hospitalized community-acquired pneumonia in the elderly - Age- and sex-related patterns of care and outcome in the united states

V Kaplan et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)

Article Critical Care Medicine

Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome

JC Marshall

CRITICAL CARE MEDICINE (2001)

Article Critical Care Medicine

Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation

P Enkhbaatar et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)